Physician

Nathan E Langer, M.D.

According to 2025 Medicare claims, Nathan Langer, M.D. (NPI: 1225230030) practices hematology/oncology in the Richmond, VA market, with the plurality of this provider's patient population coming from Prince George, VA. This provider's primary affiliated billing organization is VIRGINIA CANCER INSTITUTE INCORPORATED (NPI: 1730130980; TIN: 54-1066435) and primary practice location at 23805-0002.

Langer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 634 traditional Medicare patients, billed 82,744 HCPCS/CPT codes, and received $1,919,877 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,012 prescription claims across 166 beneficiaries totaling $3,015,796 in drug costs, led by Revlimid (Lenalidomide). 2016 DME data shows 45 claims. Open Payments data shows 86 records totaling $2,032. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $44,409 to $1,919,877. Similarly, Part D prescription costs have risen steadily, from $972,803 to $3,015,796. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.5M2015 Medicare payment: $44,409 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $51,498 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $80,882 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,129,832 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,124,483 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,431,715 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,486,902 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,439,198 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,463,361 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,919,877 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153241,155$44,409
20163481,003$51,498
20174185,572$80,882
201858687,943$1,129,832
2019691193,505$2,124,483
2020677130,900$2,431,715
2021708143,355$2,486,902
2022707138,644$2,439,198
2023648128,453$2,463,361
202463482,744$1,919,877

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$3.0M2015 Drug cost: $972,803 (USD; Tot_Drug_Cst)2016 Drug cost: $1,259,463 (USD; Tot_Drug_Cst)2017 Drug cost: $1,593,973 (USD; Tot_Drug_Cst)2018 Drug cost: $474,573 (USD; Tot_Drug_Cst)2019 Drug cost: $1,666,708 (USD; Tot_Drug_Cst)2020 Drug cost: $2,349,799 (USD; Tot_Drug_Cst)2021 Drug cost: $2,576,916 (USD; Tot_Drug_Cst)2022 Drug cost: $2,332,482 (USD; Tot_Drug_Cst)2023 Drug cost: $1,875,851 (USD; Tot_Drug_Cst)2024 Drug cost: $3,015,796 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015161921$972,803
20161721,033$1,259,463
20171851,053$1,593,973
2018125500$474,573
2019117754$1,666,708
2020120932$2,349,799
2021139867$2,576,916
20221501,001$2,332,482
2023146894$1,875,851
20241661,012$3,015,796

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.3K$2.6K2016 Medicare payment: $2,624 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R45$2,624
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more115405$91
96413Administration of chemotherapy into vein, 1 hour or less92282$91
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more316672$61
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's199277$12
96372Injection of drug or substance under skin or into muscle86196$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide501,400$974,081
ImbruvicaIbrutinib19756$441,928
PomalystPomalidomide13364$292,240
TagrissoOsimertinib Mesylate12360$206,969
MekinistTrametinib Dimethyl Sulfoxide12360$186,299

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.86$2,032Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Nathan E. Langer, M.D.?

Tedicare shows public-source Medicare data for Nathan E. Langer, M.D. (NPI 1225230030), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nathan E. Langer, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nathan E. Langer, M.D.?

Nathan E. Langer, M.D. is linked to VIRGINIA CANCER INSTITUTE INCORPORATED (billing NPI 1730130980) in the available physician profile data.

Does Nathan E. Langer, M.D. have Open Payments data?

Nathan E. Langer, M.D. has 86 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.